https://www.ndtvprofit.com/markets/emcure-pharma-subscribe-for-long-term-motilal-oswal-9981969
Emcure Pharma IPO - Subscribe For Long Term: Motilal Oswal
The Rs 1,952 crore IPO consists of fresh issue of Rs 800 crore and offer for sale of Rs 1150 crore by promoters and investor selling shareholder
emcure pharmalong termiposubscribemotilal
https://www.ndtvprofit.com/markets/emcure-pharma-shares-hit-record-high-after-large-trades-11424508
Emcure Pharma Shares Hit Record High After Large Trades
The stock hit Rs 1,769 on the NSE, rising 10%, compared to a 1.4% jump in the benchmark Nifty 50 and nearly 1% advance in the Nifty Pharma index.
emcure pharmahit recordshareshighlarge
https://www.financialexpress.com/business/industry-emcure-pharma-net-profit-up-23-6-to-rs-244-crore-4232748/
Emcure Pharma net profit up 23.6% to Rs 244 crore - Industry News | The Financial Express
Emcure Pharmaceuticals reported a 23.6% rise in Q4 net profit to Rs 244 crore, with revenue growing 16.7% to Rs 2,470 crore, driven by strong international...
https://www.business-standard.com/amp/markets/capital-market-news/emcure-pharma-s-maharashtra-facility-gets-2-usfda-observations-125022600385_1.html
Emcure Pharma's Maharashtra facility gets 2 USFDA observations | Capital Market News - Business...
Emcure Pharmaceuticals has announced that the United States Food and Drug Administration (USFDA) had conducted a current Good Manufacturing Practices (cGMP)...
https://www.businesstoday.in/india/story/hate-marketing-vs-a-class-act-shark-tanks-namita-thapar-on-ramdevs-sharbat-jihad-remark-473116-2025-04-22
'Hate marketing vs a class act...': Emcure Pharma's Namita Thapar on Ramdev's 'Sharbat Jihad'...
Apr 22, 2025 - Emcure Pharmaceuticals' Namita Thapar criticised Ramdev's 'sharbat jihad' comments as hate marketing, while praising Rooh Afza for its response.
https://www.businesstoday.in/markets/company-stock/story/emcure-pharma-shares-make-a-strong-d-st-debut-stock-lists-at-31-premium-436538-2024-07-10
Emcure Pharma shares make a strong D St debut, stock lists at 31% premium - BusinessToday
Jul 10, 2024 - Shares of Emcure Pharma were commanding a grey market premium of Rs 390-400 on the last day of the bidding for the issue, before the allotment was announced.
https://www.indiatoday.in/business/story/ola-electric-emcure-pharma-sebi-green-signal-initial-public-offerings-2555692-2024-06-20
Ola Electric, Emcure Pharma get Sebi nod for IPOs. Check details - India Today
Jun 20, 2024 - Following Sebi's approval, Ola Electric and Emcure Pharmaceuticals are expected to launch their IPOs in the coming months.
https://www.ndtvprofit.com/markets/q4-results-tomorrow-coforge-larsen-and-toubro-raymond-emcure-pharma-mahindra-and-mahindra-among-60-companies-to-declare-earnings-11445533
Q4 Results Today: Coforge, Larsen And Toubro, Raymond, Emcure Pharma, Mahindra And Mahindra Among...
United Breweries, Raymond Realty, Shoppers Stop and Punjab National Bank are among the companies slated to declare earnings on May 5.
larsen and toubroresults today
https://www.financialexpress.com/business/news/emcure-pharma-net-up-48-completes-roll-out-of-semiglutide-drug/4131274/
Emcure Pharma net up 48%, completes roll out of Semiglutide drug - Business News | The Financial...
The company's strong performance was driven by growth in key therapy areas across both domestic and international markets, particularly in chronic conditions...
https://www.indiatimes.com/worth/investment/shark-tank-india-judge-namita-thapars-emcure-pharma-set-to-launch-ipo-soon-her-net-worth-is-rs-600-crore/articleshow/122476357.html
Shark Tank India Judge Namita Thapar's Emcure Pharma Set To Launch IPO Soon, Her Net Worth Is Rs...
Namita Thapar, who is the Executive Director (India Business) of Emcure Pharmaceuticals, had said earlier this month at the ET NOW Global Business Summit 2024...